BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. Cancer. 2016;122:693-701. [PMID: 26717303 DOI: 10.1002/cncr.29840] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clinical Colorectal Cancer 2017;16:220-7. [DOI: 10.1016/j.clcc.2016.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Aparicio T, Henriques J, Manfredi S, Tougeron D, Bouché O, Pezet D, Piessen G, Coriat R, Zaanan A, Legoux JL, Terrebone E, Pocard M, Gornet JM, Lecomte T, Lombard-Bohas C, Perrier H, Lecaille C, Lavau-Denes S, Vernerey D, Afchain P; NADEGE Investigators. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. Int J Cancer 2020;147:967-77. [PMID: 31912484 DOI: 10.1002/ijc.32860] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
3 Datta J, Ecker BL, Neuwirth MG, Geha RC, Fraker DL, Roses RE, Karakousis GC. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature. Surg Oncol. 2017;26:117-124. [PMID: 28577717 DOI: 10.1016/j.suronc.2017.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
4 Gelsomino F, Balsano R, De Lorenzo S, Garajová I. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology 2022;29:1223-36. [DOI: 10.3390/curroncol29020104] [Reference Citation Analysis]
5 Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). J Oncol Pract 2018;14:e631-43. [PMID: 30207852 DOI: 10.1200/JOP.18.00175] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
6 Nitta N, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Sasaki K, Uesaka K. Prognostic Impact of Pancreatic Invasion in Duodenal Carcinoma: A Single-Center Experience. Ann Surg Oncol 2020;27:4553-60. [PMID: 32367502 DOI: 10.1245/s10434-020-08512-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Vanoli A, Grillo F, Guerini C, Neri G, Arpa G, Klersy C, Nesi G, Giuffrida P, Sampietro G, Ardizzone S, Fociani P, Fiocca R, Latella G, Sessa F, D'Errico A, Malvi D, Mescoli C, Rugge M, Ferrero S, Poggioli G, Rizzello F, Macciomei MC, Santini D, Volta U, De Giorgio R, Caio G, Calabrò A, Ciacci C, D'Armiento M, Rizzo A, Solina G, Martino M, Tonelli F, Villanacci V, Cannizzaro R, Canzonieri V, Florena AM, Biancone L, Monteleone G, Caronna R, Ciardi A, Elli L, Caprioli F, Vecchi M, D'Incà R, Zingone F, D'Odorico A, Lenti MV, Oreggia B, Reggiani Bonetti L, Giannone AG, Orlandi A, Barresi V, Ciccocioppo R, Amodeo G, Biletta E, Luinetti O, Pedrazzoli P, Pietrabissa A, Corazza GR, Solcia E, Paulli M, Di Sabatino A. Prognostic Role of Mismatch Repair Status, Histotype and High-Risk Pathologic Features in Stage II Small Bowel Adenocarcinomas. Ann Surg Oncol 2021;28:1167-77. [PMID: 32761330 DOI: 10.1245/s10434-020-08926-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
9 Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis. Ann Surg Oncol. 2017;24:3926-3933. [PMID: 28952140 DOI: 10.1245/s10434-017-6095-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
10 Huffman BM, Jin Z, Yadav S, Patel S, Nagorney DM, Truty MJ, McWilliams RR, Halfdanarson TR, Mahipal A. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. Clin Colorectal Cancer 2019;18:218-25. [PMID: 31178274 DOI: 10.1016/j.clcc.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Ecker BL, Peters MG, Mcmillan MT, Sinnamon AJ, Zhang PJ, Kelz RR, Roses RE, Drebin JA, Fraker DL, Karakousis GC. Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma. Ann Surg Oncol 2017;24:425-33. [DOI: 10.1245/s10434-016-5641-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
12 Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415 [PMID: 29085567 DOI: 10.4251/wjgo.v9.i10.407] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
13 Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T. Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study. Eur J Surg Oncol 2019;45:331-5. [PMID: 30501999 DOI: 10.1016/j.ejso.2018.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Locher C, Batumona B, Afchain P, Carrère N, Samalin E, Cellier C, Aparicio T, Becouarn Y, Bedenne L, Michel P, Parc Y, Pocard M, Chibaudel B, Bouché O. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Digestive and Liver Disease 2018;50:15-9. [DOI: 10.1016/j.dld.2017.09.123] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
15 Moekotte AL, Malleo G, van Roessel S, Bonds M, Halimi A, Zarantonello L, Napoli N, Dreyer SB, Wellner UF, Bolm L, Mavroeidis VK, Robinson S, Khalil K, Ferraro D, Mortimer MC, Harris S, Al-Sarireh B, Fusai GK, Roberts KJ, Fontana M, White SA, Soonawalla Z, Jamieson NB, Boggi U, Alseidi A, Shablak A, Wilmink JW, Primrose JN, Salvia R, Bassi C, Besselink MG, Abu Hilal M. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Br J Surg 2020;107:1171-82. [PMID: 32259295 DOI: 10.1002/bjs.11555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
16 Linden K, Melillo A, Gaughan J, Obinero C, Kellish A, Wozniak MR, Patel RM, Pandya V, Atabek U, Spitz F, Hong YK. The Role of Neoadjuvant Versus Adjuvant Therapy for Duodenal Adenocarcinoma: A National Cancer Database Propensity Score Matched Analysis. Am Surg 2021;87:1066-73. [PMID: 33291951 DOI: 10.1177/0003134820954821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Singh H, Krishnamurthy G, Kumar H, Mandavdhare H, Sharma V, Yadav TD. Surgical Management of Jejunal Tumors: Experience from Tertiary Care Centre. J Gastrointest Cancer 2020;51:901-7. [PMID: 31705396 DOI: 10.1007/s12029-019-00327-5] [Reference Citation Analysis]
18 Zhao P, Chen H, Wen D, Mou S, Zhang F, Zheng S. Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma. Cancer Commun (Lond) 2018;38:54. [PMID: 30139386 DOI: 10.1186/s40880-018-0323-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Legué LM, Bernards N, Gerritse SL, van Oudheusden TR, de Hingh IH, Creemers GM, Ten Tije AJ, Lemmens VE. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands. Acta Oncol 2016;55:1183-9. [PMID: 27170100 DOI: 10.1080/0284186X.2016.1182211] [Cited by in Crossref: 39] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
20 Zhang S, Yuan W, Zhang J, Chen Y, Zheng C, Ma J, Jiang Q, Zhao Y, Xu Q, Wang C. Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma. Medicine (Baltimore) 2017;96:e7713. [PMID: 28767610 DOI: 10.1097/MD.0000000000007713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Khosla D, Dey T, Madan R, Gupta R, Goyal S, Kumar N, Kapoor R. Small bowel adenocarcinoma: An overview. World J Gastrointest Oncol 2022; 14(2): 413-422 [DOI: 10.4251/wjgo.v14.i2.413] [Reference Citation Analysis]
22 Fields AC, Lu PW, Li GZ, Welten V, Jolissaint JS, Vierra BM, Saadat LV, Larson AC, Atkinson RB, Melnitchouk N. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Curr Probl Surg 2020;57:100727. [PMID: 32151327 DOI: 10.1016/j.cpsurg.2019.100727] [Reference Citation Analysis]
23 Duerr D, Ellard S, Zhai Y, Taylor M, Rao S. A Retrospective Review of Chemotherapy for Patients with Small Bowel Adenocarcinoma in British Columbia. J Cancer 2016;7:2290-5. [PMID: 27994666 DOI: 10.7150/jca.16606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
24 Pourmand K, Itzkowitz SH. Small Bowel Neoplasms and Polyps. Curr Gastroenterol Rep 2016;18:23. [PMID: 27086004 DOI: 10.1007/s11894-016-0497-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
25 Yu IS, Al-Hashami Z, Chapani P, Speers C, Davies JM, Lim HJ, Renouf DJ, Gill S, Stuart HC, Loree JM. Impact of Tumor Location on Patient Outcomes in Small Bowel Cancers. Clin Colorectal Cancer 2021:S1533-0028(21)00129-8. [PMID: 34972663 DOI: 10.1016/j.clcc.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database. Int J Clin Oncol 2018;23:473-81. [DOI: 10.1007/s10147-017-1226-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Manley J, Ibrahim Y, Ansell J, Alastal H, Rasheed A. Small bowel adenocarcinoma: Case reports and review of the literature. Arab J Gastroenterol 2021;22:240-5. [PMID: 34531134 DOI: 10.1016/j.ajg.2021.07.003] [Reference Citation Analysis]
28 de Jong EJM, van der Geest LG, Besselink MG, Bouwense SAW, Buijsen J, Dejong CHC, Koerkamp BG, Heij LR, de Hingh IHJT, Hoge C, Kazemier G, van Laarhoven HWM, de Meijer VE, Stommel MWJ, Tjan-Heijnen VCG, Valkenburg-van Iersel LBJ, Wilmink JW, Geurts SME, de Vos-Geelen J; Dutch Pancreatic Cancer Group. Treatment and overall survival of four types of non-metastatic periampullary cancer: nationwide population-based cohort study. HPB (Oxford) 2022:S1365-182X(22)00044-2. [PMID: 35135724 DOI: 10.1016/j.hpb.2022.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Akce M, Jiang R, Zakka K, Wu C, Alese OB, Shaib WL, Behera M, El-Rayes BF. Clinical Outcomes of Small Bowel Adenocarcinoma. Clin Colorectal Cancer 2019;18:257-68. [PMID: 31606297 DOI: 10.1016/j.clcc.2019.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
30 Lee TC, Wima K, Morris MC, Winer LK, Sussman JJ, Ahmad SA, Wilson GC, Patel SH. Small Bowel Adenocarcinomas: Impact of Location on Survival. J Surg Res 2020;252:116-24. [PMID: 32278965 DOI: 10.1016/j.jss.2020.03.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Thiessen M, Lee-Ying RM, Monzon JG, Tang PA. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis. J Gastrointest Cancer 2020;51:280-8. [PMID: 31111426 DOI: 10.1007/s12029-019-00250-9] [Reference Citation Analysis]
32 Lech G, Korcz W, Kowalczyk E, Słotwiński R, Słodkowski M. Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome. Scand J Gastroenterol 2017;52:1194-202. [PMID: 28737049 DOI: 10.1080/00365521.2017.1356932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
33 Sankari Tarabishi A, Aljarad Z, Shebli B, Masri AH, Anadani R, Shabouk MB, Trissi M. A rare case of bowel intussusception due to adenocarcinomatous polyp in a 14 year-old child: case report. BMC Surg 2020;20:198. [PMID: 32917174 DOI: 10.1186/s12893-020-00859-9] [Reference Citation Analysis]
34 Abudalou M, Al Sbihi AF, Perepletchikov A, Stallwood C. Small Intestinal Adenocarcinoma in a Patient With Celiac Disease. Cureus 2021;13:e13039. [PMID: 33665060 DOI: 10.7759/cureus.13039] [Reference Citation Analysis]
35 Bowitz Lothe IM, Kleive D, Pomianowska E, Cvancarova M, Kure E, Dueland S, Gladhaug IP, Labori KJ. Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: Pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy. Pancreatology 2019;19:316-24. [PMID: 30713128 DOI: 10.1016/j.pan.2019.01.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wu S, Chen JN, Zhang QW, Tang CT, Zhang XT, Tang MY, Li XB, Ge ZZ. A New Metastatic Lymph Node Classification-based Survival Predicting Model in Patients With Small Bowel Adenocarcinoma: A Derivation and Validation Study. EBioMedicine 2018;32:134-41. [PMID: 29908920 DOI: 10.1016/j.ebiom.2018.05.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
37 Yanko E, Le D, Mahmood S, Ginther DN, Chalchal HI, Kanthan R, Haider K, Zaidi A, Dueck DA, Ahmed O, Gowrishankar B, Ahmed S. Outcomes of Patients with Small Intestine Adenocarcinoma in a Canadian Province: A Retrospective Multi-Center Population-Based Cohort Study. Cancers (Basel) 2022;14:2581. [PMID: 35681560 DOI: 10.3390/cancers14112581] [Reference Citation Analysis]
38 Kaslow SR, Prendergast K, Vitiello GA, Hani L, Berman RS, Lee AY, Correa-gallego C. Systemic therapy for duodenal adenocarcinoma: An analysis of the National Cancer Database (NCDB). Surgery 2022. [DOI: 10.1016/j.surg.2022.03.009] [Reference Citation Analysis]
39 de Bree E, Rovers KP, Stamatiou D, Souglakos J, Michelakis D, de Hingh IH. The evolving management of small bowel adenocarcinoma. Acta Oncol 2018;57:712-22. [PMID: 29381126 DOI: 10.1080/0284186X.2018.1433321] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
40 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Kim CY, Collier CD, Liu RW, Getty PJ. Are Limb-sparing Surgical Resections Comparable to Amputation for Patients With Pelvic Chondrosarcoma? A Case-control, Propensity Score-matched Analysis of the National Cancer Database. Clin Orthop Relat Res 2019;477:596-605. [PMID: 30762693 DOI: 10.1097/CORR.0000000000000622] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Gu Y, Deng H, Wang D, Li Y. Metastasis Pattern and Survival Analysis in Primary Small Bowel Adenocarcinoma: A SEER-Based Study. Front Surg 2021;8:759162. [PMID: 34950695 DOI: 10.3389/fsurg.2021.759162] [Reference Citation Analysis]
43 Xie X, Zhou Z, Song Y, Dang C, Zhang H. Surgical Management and Prognostic Prediction of Adenocarcinoma of Jejunum and Ileum. Sci Rep 2017;7:15163. [PMID: 29123252 DOI: 10.1038/s41598-017-15633-w] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Puccini A, Battaglin F, Lenz HJ. Management of Advanced Small Bowel Cancer. Curr Treat Options Oncol 2018;19:69. [PMID: 30397729 DOI: 10.1007/s11864-018-0592-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Fu Y, Zheng C, Huang J, Wu S, Dai Y. Duodenal adenocarcinoma with skin metastasis as initial manifestation: A case report. Open Life Sci 2021;16:395-8. [PMID: 33981846 DOI: 10.1515/biol-2021-0029] [Reference Citation Analysis]
46 Hao M, Xia H, Duan J, Zhou H, Zhang G, Li D, Chen X, Wang W, Sang Y, Feng S, Liu H. A Living Material Constructed from Stem Cells for Tumor‐Tropic Oncotherapy with Real‐Time Imaging. Adv Funct Materials 2022;32:2201013. [DOI: 10.1002/adfm.202201013] [Reference Citation Analysis]
47 Li J, Wang Z, Liu N, Hao J, Xu X. Small bowel adenocarcinoma of the jejunum: a case report and literature review. World J Surg Oncol 2016;14:177. [PMID: 27402105 DOI: 10.1186/s12957-016-0932-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
48 Yang QY, Tang CT, Huang YF, Shao DT, Shu X. Development and validation of a nomogram for primary duodenal carcinoma: a multicenter, population-based study. Future Oncol 2022. [PMID: 35114801 DOI: 10.2217/fon-2021-0622] [Reference Citation Analysis]
49 Chen EY, Vaccaro GM. Small Bowel Adenocarcinoma. Clin Colon Rectal Surg 2018;31:267-77. [PMID: 30186048 DOI: 10.1055/s-0038-1660482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
50 Dai ZH, Wang QW, Zhang QW, Yan XL, Aparicio T, Zhou YY, Wang H, Zhang CH, Zaanan A, Afchain P, Zhang Y, Chen HM, Gao YJ, Ge ZZ. Personalized four-category staging for predicting prognosis in patients with small bowel Adenocarcinoma: an international development and validation study. EBioMedicine 2020;60:102979. [PMID: 32980692 DOI: 10.1016/j.ebiom.2020.102979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123:967-976. [PMID: 28263387 DOI: 10.1002/cncr.30439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
52 Takei R, Onishi I, Zaimoku R, Makita N, Yagi Y, Kayahara M. Adenocarcinoma in a Blind Loop of the Ileum 53 Years After an Ileotransversostomy Procedure. Am J Case Rep 2018;19:133-6. [PMID: 29402880 DOI: 10.12659/ajcr.907144] [Reference Citation Analysis]